<DOC>
	<DOC>NCT01743820</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety, efficacy, and pharmacokinetics of low single-dose primaquine for gametocidal activity against P.falciparum among adult glucose-6-phosphate dehydrogenase (G6PD)-normal malaria patients.</brief_summary>
	<brief_title>Phase2a Primaquine Dose Escalation Study</brief_title>
	<detailed_description />
	<mesh_term>Dihydroartemisinin</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Primaquine</mesh_term>
	<mesh_term>Piperaquine</mesh_term>
	<criteria>Male Age &gt;= 18 years and &lt; 50 years Malaria blood thick film positive Presence of gametocytes on thick blood film Agrees to admission to study ward for 26 hours post diagnosis and available for follow up visits No allergies to study drugs Hemoglobin &gt;= 8 g/dl No evidence of severe or chronic disease Written, informed consent</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>